[Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]

Ernst et al., 1996 | Fortschr Med | Systematic Review

Citation

Ernst E. [Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature]. Fortschr Med. 1996-Mar-20;114(8):85-7

Abstract

The aim of this systematic review was to evaluate the effectiveness of ginkgo biloba in the treatment of intermittent claudication. A Medline-search identified ten controlled trials on the subject. These were heterogeneous in all respects and, with only few exceptions, of poor methodological quality. All the studies implied that ginkgo biloba is an effective therapy for intermittent claudication. This hypothesis should be confirmed in further trials employing meticulous methodology. Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.

Key Findings

Furthermore it would also be important to determine whether oral ginkgo biloba can be usefully combined with walking exercise.

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Clinical Trials as Topic
  • Diterpenes
  • Double-Blind Method
  • Fibrinolytic Agents
  • Ginkgolides
  • Humans
  • Intermittent Claudication
  • Lactones
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Evidence Classification

  • Level: Systematic Review
  • Publication Types: Journal Article, Systematic Review
  • Vertical: ginkgo

Provenance

  • PMID: 8647571
  • DOI: (not available)
  • PMCID: Not in PMC
  • Verified: 2026-04-09 via PubMed E-utilities API

Source extracted via PubMed E-utilities API on 2026-04-09